UBS/CALL/ALCON AG/90.001/0.1/21.03.25 Share Price

Warrant

NALC7U

CH1280379913

Real-time Bid/Ask 01:35:54 05/07/2024 pm IST
0.26 CHF / 0.27 CHF -1.85% Intraday chart for UBS/CALL/ALCON AG/90.001/0.1/21.03.25
3 months+28.57%
6 months+200.00%
Date Price Change
04/24/04 0.27 +12.50%
03/24/03 0.24 -7.69%
02/24/02 0.26 -3.70%

Delayed Quote Swiss Exchange

Last update July 04, 2024 at 08:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ALCON INC.
Issuer UBS
NALC7U
ISINCH1280379913
Date issued 18/09/2023
Strike 90 CHF
Maturity 21/03/2025 (260 Days)
Parity 10 : 1
Emission price 0.31 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.38 CHF
Lowest since issue 0.09 CHF
Delta0.32x
Omega 9.451
Premium14.93x
Gearing29.35x
Moneyness 0.8967
Difference Strike 9.511 CHF
Difference Strike %+10.57%
Spread 0.01 CHF
Spread %3.57%
Theoretical value 0.2750
Implied Volatility 20.94 %
Total Loss Probability 73.69 %
Intrinsic value 0.000000
Present value 0.2750
Break even 92.75 CHF
Theta-0.01x
Vega0.02x
Rho0.02x

Company Profile

Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Sector
-
More about the company

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Alcon Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
89.81 USD
Average target price
93.95 USD
Spread / Average Target
+4.61%
Consensus
  1. Stock Market
  2. Warrants
  3. NALC7U Warrant